Your browser is no longer supported. Please, upgrade your browser.
Settings
INSY INSYS Therapeutics, Inc. daily Stock Chart
INSY [NASD]
INSYS Therapeutics, Inc.
Index- P/E33.75 EPS (ttm)0.32 Insider Own0.20% Shs Outstand72.49M Perf Week-9.25%
Market Cap775.64M Forward P/E19.18 EPS next Y0.56 Insider Trans-12.17% Shs Float22.99M Perf Month-10.76%
Income24.00M PEG1.21 EPS next Q0.04 Inst Own47.40% Short Float76.88% Perf Quarter-29.88%
Sales275.40M P/S2.82 EPS this Y49.20% Inst Trans-4.58% Short Ratio23.95 Perf Half Y-33.25%
Book/sh3.75 P/B2.85 EPS next Y63.16% ROA7.00% Target Price19.60 Perf Year-62.14%
Cash/sh2.34 P/C4.57 EPS next 5Y28.00% ROE9.30% 52W Range10.01 - 31.22 Perf YTD-62.63%
Dividend- P/FCF15.42 EPS past 5Y28.50% ROI22.80% 52W High-65.73% Beta0.96
Dividend %- Quick Ratio2.70 Sales past 5Y- Gross Margin92.00% 52W Low6.89% ATR0.86
Employees510 Current Ratio3.10 Sales Q/Q-39.50% Oper. Margin13.10% RSI (14)38.27 Volatility5.64% 7.07%
OptionableYes Debt/Eq0.00 EPS Q/Q-99.30% Profit Margin8.70% Rel Volume1.14 Prev Close11.24
ShortableYes LT Debt/Eq0.00 EarningsNov 03 BMO Payout0.00% Avg Volume737.97K Price10.70
Recom1.80 SMA20-15.94% SMA50-11.27% SMA200-26.48% Volume842,360 Change-4.80%
Sep-22-16Reiterated RBC Capital Mkts Outperform $32 → $26
Apr-12-16Reiterated Jefferies Buy $23 → $17
Apr-11-16Reiterated Piper Jaffray Overweight $46 → $28
Feb-24-16Reiterated Jefferies Buy $36 → $23
Feb-01-16Reiterated RBC Capital Mkts Outperform $49 → $44
Mar-09-15Reiterated RBC Capital Mkts Outperform $65 → $71
Mar-04-15Reiterated RBC Capital Mkts Outperform $57 → $65
Dec-15-14Reiterated RBC Capital Mkts Outperform $53 → $57
Nov-12-14Reiterated RBC Capital Mkts Outperform $51 → $53
Nov-12-14Downgrade Oppenheimer Outperform → Perform $40
Oct-02-14Initiated RBC Capital Mkts Outperform $51
Aug-14-13Reiterated Oppenheimer Outperform $23 → $27
Jul-31-13Initiated Oppenheimer Outperform $23
Dec-07-16 03:09PM  Canadian Marijuana Market More Mature, Outperforms U.S. Market
10:27AM  [video]4 Stocks You Can Buy to Profit From the Rising Use of Medical Marijuana
Dec-05-16 03:06PM  Top Marijuana Stocks to Buy in 2017 at Motley Fool
12:14PM  ETFs with exposure to INSYS Therapeutics, Inc. : December 5, 2016
Dec-03-16 03:37PM  Rating Marijuana Stocks: Less Risky, More Risky, Most Risky at Motley Fool
Dec-02-16 02:47PM  The Worst Marijuana Stocks in 2016 at Motley Fool
Nov-23-16 01:06PM  ETFs with exposure to INSYS Therapeutics, Inc. : November 23, 2016
08:30AM  Fentanyl billionaire comes under fire as death toll mounts from prescription opioids at MarketWatch
07:31AM  INSYS Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : INSY-US : November 23, 2016
Nov-22-16 11:52PM  [$$] Fentanyl Billionaire Comes Under Fire as Death Toll Mounts From Prescription Opioids at The Wall Street Journal -7.47%
05:24PM  Medtronic, Patterson Among Day's Biggest Losers, Trump Continues to Pressure Healthcare Sector
11:14AM  [$$] Fentanyl Billionaire Comes Under Fire as Death Toll Mounts From Prescription Opioids at The Wall Street Journal
Nov-18-16 09:43AM  INSYS Therapeutics, Inc. :INSY-US: Earnings Analysis: Q3, 2016 By the Numbers : November 18, 2016
07:00AM  Insys Therapeutics, Inc. to Present at Piper Jaffray 28th Annual Healthcare Conference GlobeNewswire
Nov-15-16 07:07AM  Even in a Trump Presidency, Marijuana Is a Good Investment
Nov-12-16 11:41AM  What's Next for Marijuana Stocks Now That Trump's Won? at Motley Fool
Nov-11-16 01:04PM  INSYS THERAPEUTICS, INC. Financials
07:06AM  INSYS Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : INSY-US : November 11, 2016
Nov-09-16 04:09PM  Nasdaq Cannabis Stocks Rally After Recreational and Medical Use Passes +15.40%
12:50PM  Marijuana Vote Could Boost These Stocks (SMG, INSY) at Investopedia
Nov-08-16 03:42PM  INSYS Therapeutics, Inc.: Gathering momentum, can it sustain its performance?
Nov-07-16 03:52PM  Nasdaq Cannabis Stocks Spike in Volume Ahead of Election for Recreational and Medical Use +12.16%
Nov-04-16 04:07PM  There's an alliance fighting to keep marijuana illegal +6.69%
02:01PM  Edited Transcript of INSY earnings conference call or presentation 3-Nov-16 2:00pm GMT
Nov-03-16 10:58AM  Insys Therapeutics tops 3Q profit forecasts
09:02AM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
08:36AM  Insys Therapeutics Pops On Earnings Beat, But Revenues Plunge at Forbes
07:07AM  Q3 2016 INSYS Therapeutics Inc Earnings Release - Before Market Open
07:00AM  Insys Therapeutics Reports Third Quarter 2016 Results GlobeNewswire
Oct-29-16 02:01PM  5 Charts That Explain the Best Marijuana Stock at Motley Fool
Oct-27-16 05:00PM  Insys Therapeutics to Report Third Quarter 2016 Results GlobeNewswire
Oct-26-16 07:48AM  Big Pharma Is Fighting Legalized Marijuana Any Way It Can
Oct-19-16 01:30PM  Business owners replace idealists in legal-pot movement
Oct-15-16 05:11PM  How the Opioid Epidemic Is Changing 2 Drugmakers' Fortunes at Motley Fool
Oct-14-16 02:41PM  2 Marijuana Stocks That Are Going in Opposite Directions at Motley Fool -6.36%
09:49AM  New Colombia Resources Forming Joint Venture to Apply for an Orphan Drug Designation with the Food and Drug Administration (FDA) for a Medical Cannabis Pharmaceutical Product PR Newswire
Oct-13-16 09:29AM  Falling Earnings Estimates Signal Weakness Ahead for INSYS Therapeutics (INSY)
06:50AM  Insys Therapeutics Reports Preliminary Estimated Revenues from Subsys for the Third Quarter 2016 GlobeNewswire
Oct-06-16 03:29PM  Why This Marijuana Stock Crashed 18% in September at Motley Fool
Oct-04-16 10:00AM  ETFs with exposure to INSYS Therapeutics, Inc. : October 4, 2016
08:00AM  INSYS Therapeutics (INSY) in Focus: Stock Jumps 7.1%
Sep-29-16 01:21PM  Ex-Insys sales manager arrested in fentanyl-kickback case -U.S. prosecutors Reuters -5.03%
Sep-26-16 04:28PM  GW Rockets On Cannabis-Tied Epilepsy Drug Trial Success
09:17AM  Healthcare Sector Earnings Review for Healthways, Amphastar Pharma, Pacira Pharma, and Insys Therapeutics
Sep-22-16 07:00AM  Cannabis Attracting Mainstream Research Analysts at Forbes
Sep-21-16 11:01AM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
07:00AM  Insys Therapeutics Announces CEO Succession Plan GlobeNewswire
Sep-15-16 03:00PM  The Cannabis-Based Biotech Sector's Best Buyout Candidates at Forbes
10:07AM  ETFs with exposure to INSYS Therapeutics, Inc. : September 15, 2016
Sep-13-16 04:45PM  A pharmaceutical company is fighting marijuana legalization because it would significantly limit the commercial success of one of its drugs -7.32%
Sep-12-16 10:52AM  How Hedge Funds Were Passing Around Marijuana Stocks in Q2 at Insider Monkey
Sep-11-16 03:57PM  Want a Pure-Play Marijuana Stock? Your Choices Are Few at Motley Fool
Sep-09-16 02:02PM  INSYS Therapeutics, Inc. Value Analysis (NASDAQ:INSY) : September 9, 2016 -7.21%
Sep-08-16 08:14AM  INSYS Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : INSY-US : September 8, 2016
Sep-07-16 05:24PM  GW Pharmaceuticals Stock Pops On Report Of Buyout Interest +5.22%
Sep-06-16 08:31AM  What Makes INSYS Therapeutics (INSY) a Strong Sell?
Sep-02-16 10:11AM  10 Conditions That Could Soon Be Treated With Cannabis: From Menstrual Cramps To Autism
Sep-01-16 07:00AM  Insys Therapeutics, Inc. to Present at Morgan Stanley Global Healthcare Conference GlobeNewswire
Aug-30-16 08:07AM  Purcell Julie & Lefkowitz LLP Is Investigating Insys Therapeutics, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
Aug-26-16 08:13AM  INSYS Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : INSY-US : August 26, 2016
Aug-25-16 12:31PM  Illinois attorney general sues Insys over fentanyl drug marketing Reuters
Aug-24-16 12:48PM  Biotech gains amid buyout chatter, upbeat clinical trial results at CNBC
12:02PM  ETFs with exposure to INSYS Therapeutics, Inc. : August 24, 2016
06:50AM  Insys Therapeutics Reports Phase 3 Trial of Sublingual Buprenorphine Spray Met Primary Endpoint in Patients with Moderate-to-Severe Postoperative Pain after Bunionectomy GlobeNewswire
Aug-23-16 09:06AM  2 Big Back-Alley Brawls Break Out in Washington Over Policy at Motley Fool
Aug-21-16 08:02PM  Harvard Explains The Health Effects Of Medical And Recreational Use Of Marijuana
Aug-19-16 05:32PM  Insys Therapeutics Starts Enrollment in Cannabidiol Trial
Aug-18-16 06:50AM  Insys Therapeutics Announces First Patient Enrolled in Phase II Trial for the Treatment of Cocaine Dependence Using Pharmaceutical Cannabidiol GlobeNewswire
Aug-17-16 05:28PM  Ex-Insys employees plead not guilty in U.S. drug-kickback case Reuters -7.09%
Aug-13-16 03:18PM  Did the DEA Just Give These Marijuana Companies a Big Break? at Motley Fool
Aug-11-16 11:45AM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
09:15AM  DEA Expected To Reject Rescheduling Of Marijuana, Expand Cultivation For Research at Forbes
08:20AM  Why Jefferies Sees 3 Big Biotechs Having Key Upside Catalysts Coming at 24/7 Wall St.
Aug-10-16 08:30AM  Identifying Newest Cannabis Strains for Cancer Treatment and Other Ailments Gain Headway Behind Pharmacological Evaluations CNW Group
Aug-08-16 02:16PM  ETFs with exposure to INSYS Therapeutics, Inc. : August 8, 2016
Aug-05-16 03:14PM  INSYS THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report
11:04AM  INSYS Therapeutics, Inc. :INSY-US: Earnings Analysis: Q2, 2016 By the Numbers : August 5, 2016
Aug-04-16 04:11PM  INSYS Therapeutics, Inc.: Gathering momentum, can it sustain its performance?
Aug-03-16 02:57PM  Edited Transcript of INSY earnings conference call or presentation 3-Aug-16 2:00pm GMT +17.43%
09:02AM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
07:07AM  Q2 2016 INSYS Therapeutics Inc Earnings Release - Before Market Open
07:02AM  Insys Therapeutics tops 2Q profit forecasts
06:50AM  Insys Therapeutics Reports Second Quarter 2016 Results GlobeNewswire
Aug-02-16 08:35AM  Medical Product Stocks Earnings Preview for Aug 3: BIO, CSII & More
Aug-01-16 11:35AM  These 5 Stocks Are Set to Soar on Bullish Earnings
Jul-26-16 04:24PM  Investors Are Betting Big Against Insys Therapeutics -- Here's Why You Shouldn't at Motley Fool
09:00AM  Six Major Biotech Acquisitions You Could See In 2016 (Part 3) at Forbes
Jul-22-16 04:38PM  The Marijuana Industry Is Growing Like Weeds
10:07AM  Huge Drugmaker Fines for Bribing Healthcare Providers at Motley Fool
Jul-20-16 04:30PM  Insys Therapeutics to Report Second Quarter 2016 Results GlobeNewswire
04:20PM  This Marijuana Drugmaker Sets Its Sights on a 9-Figure Market at Motley Fool
Jul-19-16 09:04AM  How Do Healthcare Companies Market Their Products? at Motley Fool
Jul-18-16 08:30AM  Pharmaceutical Studies & Trials of Individual Cannabinoids Aim to Develop Cannabis Strains That Specifically Target Cancer Pain and Nausea CNW Group
Jul-08-16 09:15AM  Recent Market Movers - Eleven Biotherapeutics Insys Therapeutics Himax Technologies and Broadcom
Jul-06-16 09:20AM  Coverage of Top Gainers Leading Brands Himax Technologies and Insys Therapeutics
08:07AM  INSYS Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : INSY-US : July 6, 2016
Jul-05-16 06:32PM  Goldman Sachs, Halliburton and Delta fall; Clorox climbs +6.90%
05:07PM  Why Insys Therapeutics, Endeavour Silver, and Himax Technologies Jumped Today at Motley Fool
04:21PM  Insys Stock Jumps As FDA Approves Appetite-Boosting Cannabis Drug
03:42PM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Insys Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes supportive care products. The company markets Subsys, a sublingual fentanyl spray for breakthrough cancer pain in opioid-tolerant cancer patients in the United States. Its lead product candidate is Syndros, an orally administered liquid formulation of dronabinol. The company is also developing Cannabidiol Oral Solution, a synthetic cannabidiol for childhood catastrophic epilepsy syndromes; and other product candidates, including other dronabinol line extensions and sublingual spray product candidates. Insys Therapeutics, Inc. is headquartered in Chandler, Arizona.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MEYER STEVEN JDirectorNov 04Buy10.7510,000107,48944,083Nov 07 10:14 AM
MEYER STEVEN JDirectorSep 01Option Exercise13.575006,78534,083Sep 01 04:23 PM
STANLEY THEODORE HDirectorAug 16Option Exercise5.9615,00089,40017,000Aug 16 08:23 PM
STANLEY THEODORE HDirectorAug 16Sale18.0215,000270,3002,000Aug 16 08:23 PM
JOHN N KAPOOR TRUST DATED SEPT10% OwnerAug 12Buy18.575,700105,85342,430,310Aug 12 03:40 PM
FOURTEAU PATRICKDirectorAug 11Sale18.4615,000276,90049,682Aug 12 04:51 PM
BRENNAN DANIELExec VP & Chf Operations Off.Aug 09Sale19.165,781110,7521Aug 09 07:12 PM
MEYER STEVEN JDirectorAug 04Option Exercise14.081,19416,80633,583Aug 04 06:49 PM
MEYER STEVEN JDirectorJul 06Option Exercise14.4469510,03632,389Jul 06 04:12 PM
MEYER STEVEN JDirectorJun 07Option Exercise14.081,19416,80631,694Jun 07 09:33 PM
BAKER DARRYL SChief Financial OfficerMay 23Option Exercise13.5710,000135,70021,030May 23 04:40 PM
MEYER STEVEN JDirectorMay 18Option Exercise13.575006,78530,500May 18 04:39 PM
JOHN N KAPOOR TRUST DATED SEPT10% OwnerMay 12Buy12.4110,000124,11942,424,610May 12 07:06 PM
JOHN N KAPOOR TRUST DATED SEPT10% OwnerMay 11Buy12.9440,000517,70842,414,610May 12 07:06 PM
MEYER STEVEN JDirectorApr 14Option Exercise4.8712,00058,47030,000Apr 14 06:54 PM
FOURTEAU PATRICKDirectorMar 04Sale18.2215,000273,30064,682Mar 04 04:52 PM
MEYER STEVEN JDirectorFeb 05Option Exercise8.3218,000149,83018,000Feb 09 02:12 PM